United States
Biopharma Strategy & Insights Executive with 14+ years leading global commercial analytics, forecasting, decision science, and market strategy across HIV Prevention, Oncology, and Specialty Care. I specialize in integrating advanced analytics, AI, and global insights to guide high-stakes portfolio decisions, shape pipeline strategy, and support launches across the US, EU5, Canada, and Japan. At Gilead, I lead Integrated Insights for the global HIV Prevention (PrEP) portfolio, driving: Market sizing, competitive intelligence, and scenario planning Commercial strategy for next-generation PrEP modalities (LAIs, LAO's, orals) Cross-functional leadership across Global Marketing, Access, Medical, Device, HEOR, and regional affiliates AI-enabled forecasting and decision frameworks to support pipeline planning Previously at Novartis, I led Global Strategic Insights for Solid Tumors, Oncology, shaping global strategy and forecasting across major markets and building new decision frameworks for a highly complex, competitive therapeutic area. I thrive at the intersection of science, data, strategy, and storytelling, helping senior leaders make confident, evidence-based decisions that accelerate patient impact and commercial growth.
Linear/Logistic Regression, Predictive modelling, Test/Control Analysis,A/B Testing, Decision trees & Promotion/Marketing Mix